WASHINGTON (7News) — As Artificial Intelligence (AI) becomes more popular in everyday life, drug research and development companies ... or haystacks of data," said Phil Mounteney, VP of Science ...

When Genentech licensed experimental drug vixarelimab from Kiniksa ... vice president for research and early development. “We ...

Visit www.pharmacompass.com. PharmaCompass and SCORR Marketing are collaborating to provide the drug development industry with deal and pipeline data on their biopharma clients.

Relatively small and dispersed data sets and privacy issues represent two challenges in applying machine learning in drug development. Enter predictive analytics firm Owkin, which aims to ...